Germany’s CureVac starts pivotal global trial for Covid-19 vaccine, enrolls 1st participant ...News

The biopharmaceutical company CureVac said on Monday that it has enrolled the first participant in the Phase 2b/3 study of a Covid-19 vaccine candidate to assess its safety and efficacy in adults. The randomized and placebo-controlled trial called Herald may include more than 35,000 participants in Europe and Latin America, the Tübingen-based company announced. It added that the first participant has been enrolled in the pivotal study of a mRNA vaccine candidate, CvnCoV. “With the start of the pivotal Phase 2b/3 study, we have reached another important milestone in the development of our vaccine candidate,” CEO of CureVac Dr. Franz-Wer

Hence then, the article about germany s curevac starts pivotal global trial for covid 19 vaccine enrolls 1st participant was published today ( Monday 14/12/2020 - 12:45 PM ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Germany’s CureVac starts pivotal global trial for Covid-19 vaccine, enrolls 1st participant )

Also on site :

• Brownfields sind der wahre Test für die Automatisierung: So skalierte ForwardX 484 AMRs in einem laufenden Automobilwerk eines Erstausrüsters ohne Produktionsausfälle
• 1974 Yacht Rock Classic, Inspired by a College Crush, Became a Timeless Anthem of Lost Love
• Founding Member of ’80s Rock Band Announces Update on Supergroup